Phage display for target-based antibacterial drug discovery

Drug Discovery Today

Volumn 6, Issue 14, 2001, Pages 721-727

  Christensen, Dale J ^a   Gottlin, Elizabeth B ^a   Benson, R Edward ^a   Hamilton, Paul T ^a  

^a Karo Bio USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COAT PROTEIN; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; METICILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TYROSINE TRANSFER RNA LIGASE; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; CAMPYLOBACTER; CROSS RESISTANCE; CYSTIC FIBROSIS; DISEASE TRANSMISSION; DNA LIBRARY; DRUG DEVELOPMENT; DRUG TARGETING; ENZYME INHIBITION; ESCHERICHIA COLI; GENE CONSTRUCT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE DELIVERY; LIGAND BINDING; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PHAGE DISPLAY; PROTEIN IMMOBILIZATION; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; TECHNIQUE; TECHNOLOGY;

EID: 0035395224     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01853-0     Document Type: Review

References (80)

1. New directions in antibacterial research
2. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991
3. Staphylococcus aureus infections
4. Development of new antibiotic resistance in methicillin-resistant but not methicillin-susceptible Staphylococcus aureus
5. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan
6. Transfer of a conjugative transposon, Tn5397, in a model oral biofilm
7. Plasmid transfer in the animal intestine and other dynamic bacterial populations: the role of community structure and environment
8. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man
9. Drug-resistant Salmonella from animals fed antimicrobials
10. Transmission of multi-resistant strains of Salmonella typhimurium from cattle to man
11. Antimicrobial resistance: prognosis for public health
12. Antibiotic resistance: lessons for the future
13. Bacterial resistance mechanisms as therapeutic targets
14. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection
15. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations
16. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
17. Pathogenicity of microbes associated with cystic fibrosis
18. Pathogenesis of cystic fibrosis
19. The changing epidemiology of cystic fibrosis
20. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria
21. Bacterial resistance to antibiotics: the role of biofilms
22. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd
23. The complete genome sequence of Escherichia coli K-12
24. The complete genome sequence of the Gram-positive bacterium Bacillus subtilis
25. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58
26. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen
27. Complete genome sequence of an M1 strain of Streptococcus pyogenes
28. Innovative approaches to novel antibacterial drug discovery
29. A minimal gene set for cellular life derived by comparison of complete bacterial genomes
30. Global transposon mutagenesis and a minimal Mycoplasma genome
31. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface
32. Phage display
33. Detection of small-molecule enzyme inhibitors with peptides isolated from phage-displayed combinatorial peptide libraries
34. Peptides as tools in drug discovery
35. Identification of peptides that bind to the constant region of a humanized IgG1 monoclonal antibody using phage display
36. Phage display technology. Identification of peptides as model ligands for affinity chromatography
37. Convergent evolution with combinatorial peptides
38. Searching for peptide ligands with an epitope library
39. Delineation of a linear epitope by multiple peptide synthesis and phage display
40. Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1: implications for antibody-mediated PAI-1-neutralization and vitronectin-binding
41. Making antibody fragments using phage display libraries
42. Selection of high-affinity phage antibodies from phage display libraries
43. Affinity maturation of human growth hormone by monovalent phage display
44. Evolution of binding affinity in a WW domain probed by phage display
45. Functional expression and affinity selection of single-chain cro by phage display: isolation of novel DNA-binding proteins
46. Organ targeting in vivo using phage display peptide libraries
47. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis
48. Phage display for selection of novel binding peptides
49. Filamentous fusion phage cloning vectors for the study of epitopes and design of vaccines
50. Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens
51. Surface expression and ligand-based selection of cDNAs fused to filamentous phage gene VI
52. Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays
53. Analysis of PDZ domain-ligand interactions using carboxyl-terminal phage display
54. Efficient phage display of polypeptides fused to the carboxy-terminus of the M13 gene-3 minor coat protein
55. Identification of a decapeptide with the binding reactivity for tumor-associated TAG72 antigen from a phage displayed library
56. Utilization of multiple phage display libraries for the identification of dissimilar peptide motifs that bind to a B7-1 monoclonal antibody
57. Radiolabeled chemokine binding assays
58. Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays
59. Biological characterization of neurokinin antagonists discovered through screening of a combinatorial library
60. Development of a fluorescent ligand-binding assay using the acrowell filter plate
61. High throughput fluorescence polarization: a homogeneous alternative to radioligand binding for cell surface receptors
62. Peptide exosite inhibitors of factor VIIa as anticoagulants
63. Peptide agonists of the thrombopoeitin receptor as potent as the natural cytokine
64. Novel peptides selected to bind to vascular endothelial growth factor target the receptor binding site
65. Convergent evolution with combinatorial peptides
66. Binding to protein targets of peptidic leads discovered by phage display: crystal structures of streptavidin-bound linear and cyclic peptide ligands containing the HPQ sequence
67. Crystal structure of the complex between VEGF and a receptor-blocking peptide
68. The crystal structure of a GroEL/peptide complex: plasticity as a basis for substrate diversity
69. Genetic selection of peptide inhibitors of biological pathways
70. Peptide antagonists of the human estrogen receptor
71. Drug target validation: lethal infection blocked by inducible peptide